Co-Authors
This is a "connection" page, showing publications co-authored by Ralph D'Agostino and Sujethra Vasu.
Connection Strength
0.390
-
Reding KW, Ghemigian K, Carbone S, D'Agostino R, Jordan JH, Meléndez G, Lamar ZS, Klepin HD, Thomas A, Langford D, Vasu S, Hundley WG. The relationship between abdominal fat and change in left ventricular ejection fraction in cancer patients. Obes Sci Pract. 2021 Feb; 7(1):82-90.
Score: 0.047
-
Andersen MM, Ayala-Peacock D, Bowers J, Kooken BW, D'Agostino RB, Jordan JH, Vasu S, Thomas A, Klepin HD, Brown DR, Hundley WG. Effect at One Year of Adjuvant Trastuzumab for HER2+ Breast Cancer Combined with Radiation or an Anthracycline on Left Ventricular Ejection Fraction. Am J Cardiol. 2020 06 15; 125(12):1906-1912.
Score: 0.045
-
Suerken CK, D'Agostino RB, Jordan JH, Meléndez GC, Vasu S, Lamar ZS, Hundley WG. Simultaneous Left Ventricular Volume and Strain Changes During Chemotherapy Associate With 2-Year Postchemotherapy Measures of Left Ventricular Ejection Fraction. J Am Heart Assoc. 2020 01 21; 9(2):e015400.
Score: 0.045
-
Meléndez GC, Vasu S, Lesnefsky EJ, Kaplan JR, Appt S, D'Agostino RB, Hundley WG, Jordan JH. Myocardial Extracellular and Cardiomyocyte Volume Expand After Doxorubicin Treatment Similar to Adjuvant Breast Cancer Therapy. JACC Cardiovasc Imaging. 2020 04; 13(4):1084-1085.
Score: 0.044
-
Jordan JH, Castellino SM, Meléndez GC, Klepin HD, Ellis LR, Lamar Z, Vasu S, Kitzman DW, Ntim WO, Brubaker PH, Reichek N, D'Agostino RB, Hundley WG. Left Ventricular Mass Change After Anthracycline Chemotherapy. Circ Heart Fail. 2018 07; 11(7):e004560.
Score: 0.040
-
Meléndez GC, Sukpraphrute B, D'Agostino RB, Jordan JH, Klepin HD, Ellis L, Lamar Z, Vasu S, Lesser G, Burke GL, Weaver KE, Ntim WO, Hundley WG. Frequency of Left Ventricular End-Diastolic Volume-Mediated Declines in Ejection Fraction in Patients Receiving Potentially Cardiotoxic Cancer Treatment. Am J Cardiol. 2017 05 15; 119(10):1637-1642.
Score: 0.037
-
Meléndez GC, Jordan JH, D'Agostino RB, Vasu S, Hamilton CA, Hundley WG. Progressive 3-Month Increase in LV Myocardial ECV After Anthracycline-Based Chemotherapy. JACC Cardiovasc Imaging. 2017 06; 10(6):708-709.
Score: 0.035
-
Jordan JH, Vasu S, Morgan TM, D'Agostino RB, Meléndez GC, Hamilton CA, Arai AE, Liu S, Liu CY, Lima JA, Bluemke DA, Burke GL, Hundley WG. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors. Circ Cardiovasc Imaging. 2016 08; 9(8).
Score: 0.035
-
Chotenimitkhun R, D'Agostino R, Lawrence JA, Hamilton CA, Jordan JH, Vasu S, Lash TL, Yeboah J, Herrington DM, Hundley WG. Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function. Can J Cardiol. 2015 Mar; 31(3):302-7.
Score: 0.031
-
Jordan JH, D'Agostino RB, Hamilton CA, Vasu S, Hall ME, Kitzman DW, Thohan V, Lawrence JA, Ellis LR, Lash TL, Hundley WG. Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2014 Nov; 7(6):872-9.
Score: 0.031